it's almost an impossible problem based on the post-hospital care, patient status, external factors… -The discussion/conclusions miss practical elements on how these algorithms can be used in practice. How do you integrate them? Who should respond? -The authors propose a set of algorithms without a pro/con analysis. What actually makes sense from a practical point of view? Which algorithm would they go for in practice? Should they be retrained given new datasets? Say we need to apply this method to a new hospital, are there any tweaks that could improve performance? -Obviously the authors recognize the imbalance between positive and negative cases. Can they comment on retraining needed if the ratio of positives/negatives varies with new datasets?
REVIEWER

Janusz Wojtusiak George Mason University United States fo America
REVIEW RETURNED
28-Jan-2019
GENERAL COMMENTS
The authors present investigation of application of supervised learning methods to prediction of 30-day post hospitalization mortality. The presented results are good very good in terms of accuracy, although the work lacks investigation of some of the results, i.e. zero recall for AB (except overfitting justification).
The presented work is a solid application of existing ML methods to what appears to be novel data. Beyond the specific dataset used, it is not clear how much novelty is in the presented work. All of the used methods are out of the box, and there seem not to be much done in terms of construction of variables, beyond what is standard approach.
Also, there is a large body of ML work in predicting 30-day mortality as well as inpatient mortality and long-term mortality. The authors should better summarize existing work and provide proper citations. Specifically, the authors should contrast their findings to those already available in the literature.
The paper needs to be published along with appendix that is needed for reproducibility of results. While the authors provided needed information on hyperparameter tuning, it is unclear how much the used methods are sensitive to changes in parameters, i.e., how much does random forest with 120 trees outperform one with 100 trees.
To summarize, the presented work is a solid application of wellestablished methods to known problem, with main novelty being in the use of new dataset.
Please state any competing interests or state 'None declared': None declared Please leave your comments for the authors below Revision The work presents a set of predictive algorithms for identifying patients at end of life using a retrospective cohort of patients discharged from the Emergency department. The article is generally well written and the algorithm might have practical uses in the future. The following comments address several ideas raised in the article:
-Please edit the background. There is a much more important motivation than cost in the US. You're addressing patients who could be missed (in addition to non-necessary treatments that add to cost). In addition to that, the algorithm is developed on a cohort of Swedish patients-there could be differences in the healthcare systems, the mortality post-ED is different. Maybe relate the background to the co-hort and solution you have proposed… Thanks for this insightful comment. We have now rewritten the background to attain a more patientcentric perspective. Whilst using the algorithms we developed to identify fit patients who may be "erroneously" discharged from the emergency department and subsequently end up dead is an interesting use-case, our models were primarily trained to identify the multimorbid elderly at EOL (which is also supported by the relative importance of co-morbidities as a predictor in the algorithms).
To avoid any confusion about our intentions, we have further edited the last paragraph of the background section and the third paragraph of the discussion section.
-Page 7: Line 10: Please explain how confidence intervals were obtained using the bootstrap. Thanks for highlighting the need for elaboration of these details, we have now provided a clearer description in the relevant section.
-Page 7: Line 11: Define the RF algorithm Thank you for taking the time to point out this ambiguity. We are referring to the variable importance assessment tool inherent to the RandomForestsä algorithm, which is also what we use as one of the algorithms tested in the prediction task. We have now clarified this matter in direct conjunction to the first mentioning of assessing variable importance.
-Page 7: The predicted probability being >=50% is tricky and assumes a hard cut between patients. The difference between a 49% and a 51% outcome becomes binary. Thanks for making this insightful comment. Algorithm customization and thresholding is unarguably relevant to implementing methods like ours for making clinical predictions. As we feel that this is a parameter that would benefit significantly from fine-tuning in the local population where it is applied, we believe that it merits a separate analysis in a paper dedicated to the study of an actual intervention and prospective outcomes, to provide further insights into fine-tuning the algorithms. We have now clarified this rationale for chosing 50% as a binary cutoff in the strengths and limitations subsection of the discussion section.
-Regarding the features that showed a correlation with mortality: The authors need to expand on that as it's probably the most interesting part of this article. How do these features compare to clinician decision? i.e. if an expert clinician observes these features, would she/he be able to guess the risk of mortality? (Page 8) patient age and co-morbidity are clear. How much info would this add to clinicians? Plus how many features are needed to get a reasonable sensitivity/specificity? Can a reasonable result be achieved with the top 3-4 features (for example)? Thanks for bringing into light the practical applicability of the algorithms in the clinic. Whilst many previously developed risk stratification tools have been making use of linear equations that lend themselves well to translating into risk scores that can be retrieved from memory (such as CHA2DS2VASc), the flexibility and non-linearity of machine learning algorithms does not lend itself well to this type of exercise. Due to this non-linear quality, a unit increase in one risk factor is frequently not homogenous across its range (e.g. an increase in comorbidity score from 1 to 2 may be significantly different from an increase from 6 to 7). However, the advent of cloud computing and deployable infrastructure for real-time prediction tools, algorithms like the ones we have trained can be deployed into the clinician IT workflow without too much challenge. As we consciously attempt to limit this paper to the training and implementation of the algorithms rather than specific approaches to deploy such IT infrastructure, we have limited these details in the manuscript but have elaborated some in the strengths and limitations subsections to mitigate any confusion. As per your request, we undertook a post-hoc sensitivity analysis of the performance of the RF algorithm on the test set, after re-training it on the training set with the top 5 features only. The impact on performance was marginal, with exact details elaborated at the very end of the results section.
-Page 9: The authors (lines 6-10) claim that their algorithms outperform other algorithms. Can they be clear on the improvement achieved? Thanks for highlighting the need for clarification -we realized that we had omitted the benchmark measure. By indirect comparison, our algorithms achieve higher AUC than algorithms in the papers cited, which has now been clarified and quantified in the first paragraph of the discussion section.
-Page 9: The statement on clinicians making predictions on the timing of death is strange-as the authors don't predict the timing-it's almost an impossible problem based on the post-hospital care, patient status, external factors… Thanks for pointing out this ambiguity. We intended to emphasize that clinicians frequently fail to conduct timely conversations about patients' end-of-life preferences, which we believe may result from challenges in knowing when end of life is (i.e. how long time may pass by before death in a given patient). This is now clarified in the second paragraph of the discussion section.
-The discussion/conclusions miss practical elements on how these algorithms can be used in practice. How do you integrate them? Who should respond? Thanks again for emphasizing the need for practical context. This has now been elaborated in the discussion section, the next last paragraph before the strengths and limitations subsection.
-The authors propose a set of algorithms without a pro/con analysis. What actually makes sense from a practical point of view? Which algorithm would they go for in practice? Should they be retrained given new datasets? Say we need to apply this method to a new hospital, are there any tweaks that could improve performance? Thanks for pointing out the need for clarification with regards to this. We indeed believe that the algorithms should be re-trained in any new population where they are deployed. It is likely that demographic factors like comorbidities and access to care (amongst others) may vary significantly across regions and as these all may contribute to mortality risk, it is undesirable to deploy the algorithms as is in a new population without retraining. We have highlighted this need, along with more granular advice as how to optimize predictive accuracy and customize the algorithms depending on the intervention chosen to succeed it, when retrained in a new population. Moreover, the type of intervention chosen to subject patients that are identified by the algorithm to, would impact any procon analysis and we therefore suggest a prospective evaluation of the algorithm combined with a specific intervention (such as discussions about end of life care in primary care).
-Obviously the authors recognize the imbalance between positive and negative cases. Can they comment on retraining needed if the ratio of positives/negatives varies with new datasets? Thanks for highlighting the need for clarification regarding the implementation of the algorithms. For ranges of prevalence of the outcome encountered in most datasets describing comparable populations, we believe that the inverse probability weights used in this exercise would mitigate performance issues when re-training the algorithms. This is now elaborated on in the last part of the strengths and limitations section. Thanks for a thorough review and for insightful comments. The low sensitivity of AB has been expanded on under the "model performance" subsection.
The presented work is a solid application of existing ML methods to what appears to be novel data.
Beyond the specific dataset used, it is not clear how much novelty is in the presented work. All of the used methods are out of the box, and there seem not to be much done in terms of construction of variables, beyond what is standard approach. Thanks for this to-the-point comment regarding the data science pipeline deployed in our work. In order to promote reproducibility of our method on datasets from other sites, we deliberately chose out of the box algorithms and a standardized set of predictors. We have expanded more on potential ways to customize the algorithms through thresholding and on how to increase flexibility and performance by constructing ensemble predictors, in the strengths and limitations subsection. To reflect that the algorithms trained were out of the box of commonly used open source software packages, we also propose to change the manuscript title from "developing learning algorithms…" to "training learning algorithms…".
Also, there is a large body of ML work in predicting 30-day mortality as well as inpatient mortality and long-term mortality. The authors should better summarize existing work and provide proper citations. Specifically, the authors should contrast their findings to those already available in the literature. Thanks for pointing out the need for more context in conjunction to the discussion about algorithm performance. While we recognize that short term mortality prediction is a popular topic in clinical science, we judged that the main messages would be obscured by exhaustive review of previous findings. However, we have expanded the first paragraph of the discussion section with additional details about the work we cite and what measures in particular we compare our work against.
The paper needs to be published along with appendix that is needed for reproducibility of results. While the authors provided needed information on hyperparameter tuning, it is unclear how much the used methods are sensitive to changes in parameters, i.e., how much does random forest with 120 trees outperform one with 100 trees. Thanks for pointing to the merits of a thorough assessment of our approach to hyperparameter tuning. One main advantage of machine learning approaches to mortality prediction is their ability to automatically (guided by results from previous iterations on combinations of hyperparameters) finetune their performance recursively, once an optimization metric is specified. We undertook such optimization over a wide array of combinations of hyperparameters (such as number trees, depth of trees etc.), resulting in thousands of models being tested and subsequently informing successive modifications to hyperparameters. Given the large number of models tested, it would not be feasible to report the individual performance of all of them. To promote transparency and reproducibility, we chose to opt for off the shelf implementations of popular algorithms from well-known open source tools, along with reporting the ranges of hyperparameter values we searched during the optimization. Given this, our optimization scheme should be reproducible in other populations with limited effort.
To summarize, the presented work is a solid application of well-established methods to known problem, with main novelty being in the use of new dataset. 
The authors have addressed several of the comments that were raised by the two reviewers. However, the article could benefit from a good edit by a native speaker to make the ideas clearer. The weakest section is still the Background section: -The authors need to highlight the problem, briefly survey the solutions available (including competitor work) and give clear reasons on why their work is needed. We now see the competitors later on in the discussion sections, but the authors still need to tell us why this work is needed in the Background section.
-Some sentences still read very strangely: What are ambitions of care? (first sentence) The sentence on the marginal benefits and interventions need an edit. Please rephrase: We argue that the first step in improving EOL care and reducing overtreatment is to identify patients who may benefit from a proactive discussion about EOL preferences, and therefore aimed to train supervised learning algorithms to identify patients at EOL. The authors should clarify how they have chosen then top 5 features (page 13)-was it algorithm or correlation based?
REVIEWER
Janusz Wojtusiak George Mason University United States
REVIEW RETURNED
07-Mar-2019
GENERAL COMMENTS
The presented work illustrates application of machine learning algorithms to create models for predicting short-term mortality. The paper is a significant improvement over the previous version and addresses the previous concerns.
Two small issues may need to be addressed. The authors changed title of the paper. While there is no consistency in the field, the clean terminology is that ML algorithms and data are used to train models for predicting outcomes, it is not algorithms that are being trained. There is also need to provide better explanation of exposed/unexposed in table 1. Thank you for the attention you have been giving our paper. We have addressed your comments and provide a point-by-point response to them below.
VERSION 2 -AUTHOR RESPONSE
Please leave your comments for the authors below
The authors have addressed several of the comments that were raised by the two reviewers. However, the article could benefit from a good edit by a native speaker to make the ideas clearer. The weakest section is still the Background section:
-The authors need to highlight the problem, briefly survey the solutions available (including competitor work) and give clear reasons on why their work is needed. We now see the competitors later on in the discussion sections, but the authors still need to tell us why this work is needed in the Background section.
Thank you for emphasizing the need for a clearer background. We have reviewed the background section and re-worded it for clarity of the objective and included further references detailing the unmet medical need and our rationale for conducting the study.
-Some sentences still read very strangely:
What are ambitions of care? (first sentence)
The sentence on the marginal benefits and interventions need an edit.
Please rephrase: We argue that the first step in improving EOL care and reducing overtreatment is to identify patients who may benefit from a proactive discussion about EOL preferences, and therefore aimed to train supervised learning algorithms to identify patients at EOL.
We agree that these sentences could be improved for readability and have put effort into doing so. We have also made sure to discuss the sentence structure with native English speakers.
Thank you for the attention you have been giving our paper. We have addressed your comments and provide a point-by-point response to them below.
Please leave your comments for the authors below
Two small issues may need to be addressed. The authors changed title of the paper. While there is no consistency in the field, the clean terminology is that ML algorithms and data are used to train models for predicting outcomes, it is not algorithms that are being trained.
Thank you for pointing out this inconsistency. We have replaced 'algorithms' with 'models' in appropriate places in the manuscript.
There is also need to provide better explanation of exposed/unexposed in table 1.
Thank you for indicating this ambiguity. We have now added a footnote detailing our definition of 'exposed' subjects.
